NL-OMON35043招募中不适用
Imaging and angiogenesis of malignant lymphoma with dynamic MRI, H-MRS, P-MRS and FDG-PET/CT for staging, mid treatment assessment and outcome. - CILA
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •>= 18 years.
- •WHO performance status: 0-3 (see appendix 1)
- •Karnofsky score >= 80 (see appendix 2)
- •Biopsy proven de novo or relapsed malignant lymphoma of any histological subtype. Relapsed patients who participated in this study during an earlier line of treatment may be re-entered in the study when fulfilling the inclusion criteria.
- •Sufficient biopsy material present to perform anti-CD34 staining and subsequent MVD assessment.
排除标准
- •Other active malignancy (less than 5 years in complete remission) except skin carcinoma (non-melanoma).
- •HIV positive patients.
- •Patients with contra-indications for contrast enhanced MR exams:
- •o Claustrophobia,
- •o Cardiac pacemaker or pacemaker wiring in situ,
- •o Cerebral clips or metal artificial cardiac valves,
- •o Ossicle prosthesis
- •o Renal failure
- •Pregnancy or breastfeeding .
- •No staging FDG-PET/CT available.
- •Inability of giving informed consent.
研究者
相似试验
招募中
不适用
on-invasive imaging of sentinel lymph node with a Multispectral Optoacoustic Tomography (MSOT-Scanner) in patients with malignant melanomaC43Malignant melanoma of skinDRKS00006329Klinik für Dermatologie, Venerologie und AllergologieUniversitätsklinikum Essen40
进行中（未招募）
1 期
In vivo molecular imaging of angiogenesis in type 2 diabetesType 2 diabetesMedDRA version: 20.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 100000004861EUCTR2019-003466-41-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET90
进行中（未招募）
Unknown
High-resolution contrast-enhanced ultrasound and biological markers to assess the response of triple-negative breast cancer during neoadjuvant chemotherapyTriple-negative breast cancer (TNBC)Malignant neoplasm of breastCancerISRCTN85986368Maidstone and Tunbridge Wells NHS Trust5
尚未招募
不适用
Imaging tumor angiogenesis using 18F-Fluciclatide PET/CT in patients with colorectal and pancreatic cancerNL-OMON21459MC30
进行中（未招募）
1 期
Imaging tumor bloodvessels using 18F-Fluciclatide PET scan.EUCTR2018-003522-86-NLeiden University Medical Center20